Albumin‐myosteatosis gauge as a novel prognostic risk factor in patients with non‐metastatic colorectal cancer
Sign Up to like & getrecommendations! Published in 2023 at "Journal of Cachexia, Sarcopenia and Muscle"
DOI: 10.1002/jcsm.13183
Abstract: Myosteatosis and systemic inflammation are well‐known prognostic factors in patients with colorectal cancer (CRC). The serum albumin level is a reflection of malnutrition and systemic inflammation, which in turn plays a key role in the… read more here.
Keywords: albumin myosteatosis; myosteatosis; myosteatosis gauge; gauge novel ... See more keywords
Albumin-myosteatosis gauge as a prognostic biomarker in patients treated with immune checkpoint inhibitors.
Sign Up to like & getrecommendations! Published in 2025 at "Immunotherapy"
DOI: 10.1200/jco.2025.43.16_suppl.2644
Abstract: BACKGROUND Although immune checkpoint inhibitors (ICIs) have heralded a new era in cancer treatment, many patients do not respond, underscoring the need for biomarkers. The albumin-myosteatosis gauge (AMG) is a recently developed integrated measure of… read more here.
Keywords: cancer; myosteatosis gauge; immune checkpoint; albumin myosteatosis ... See more keywords